0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Clinical Trials Update | 
Anita Slomski, MA
JAMA. 2015;314(24):2608. doi:10.1001/jama.2015.16711.

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2015;314(21):2298-2299. doi:10.1001/jama.2015.14772.

JAMA Patient Page |  FREE
Jill Jin, MD, MPH
JAMA. 2015;314(21):2320. doi:10.1001/jama.2015.13748.
Includes: Supplemental Content

Original Investigation | 
David A. Asch, MD; Andrea B. Troxel, ScD; Walter F. Stewart, PhD, MPH; et al.
JAMA. 2015;314(18):1926-1935. doi:10.1001/jama.2015.14850.
Includes: Supplemental Content

Viewpoint | 
Rene Rodriguez-Gutierrez, MD; Nilay D. Shah, PhD; Victor M. Montori, MD, MSc
JAMA. 2015;314(18):1909-1910. doi:10.1001/jama.2015.13414.

Original Investigation | 
Elizabeth D. Kantor, PhD, MPH; Colin D. Rehm, PhD, MPH; Jennifer S. Haas, MD, MSc; et al.
JAMA. 2015;314(17):1818-1830. doi:10.1001/jama.2015.13766.
Includes: CME, Supplemental Content

Viewpoint | 
William H. Shrank, MD, MSHS; Jane F. Barlow, MD, MPH; Troyen A. Brennan, MD, JD
JAMA. 2015;314(14):1443-1444. doi:10.1001/jama.2015.10017.

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2015;314(13):1332. doi:10.1001/jama.2015.12087.

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2015;314(12):1284-1285. doi:10.1001/jama.2015.11372.

Clinical Trials Update | 
Anita Slomski, MA
JAMA. 2015;314(12):1217. doi:10.1001/jama.2015.11081.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Internal Medicine
Viewpoint  | 
Free Speech and Pharmaceutical Regulation—Fishy Business
Amy Kapczynski, JD
JAMA Dermatology
Original Investigation  | 
Laboratory Monitoring During Isotretinoin Therapy for Acne A Systematic Review and Meta-analysis
Young H. Lee, MD; Thomas P. Scharnitz, BS; Joshua Muscat, PhD; et al.
JAMA Internal Medicine
Invited Commentary  | 
Fitness in Young Adults as an Independent Predictor of Risk for Cardiovascular Disease
David E. Chiriboga, MD, MPH; Ira S. Ockene, MD
JAMA Internal Medicine
Evidence to Practice  | 
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Treatment of High Cholesterol Levels Effectiveness and Value
Jeffrey A. Tice, MD; Dhruv S. Kazi, MD, MSc, MS; Steven D. Pearson, MD, MSc